News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

First Patient Enrolled and Treated in the U.S. for EndoGastric Solutions, Inc.’s Randomized Study of Transoral Incisionless Fundoplication (TIF(R))


6/23/2011 11:10:06 AM

REDWOOD CITY, Calif.--(BUSINESS WIRE)--EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the first patient has been enrolled and treated in the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES